Hemorrhagic transformation after fibrinolytic therapy with tissue plasminogen activator in a rat thromboembolic model of stroke
- 27 January 2000
- journal article
- Published by Elsevier in Brain Research
- Vol. 854 (1-2) , 245-248
- https://doi.org/10.1016/s0006-8993(99)02276-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Hemispheric StrokeJAMA, 1995
- Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion.Stroke, 1994
- Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke.Stroke, 1992
- Recombinant tissue plasminogen activator in acute thrombotic and embolic strokeAnnals of Neurology, 1992
- Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset.Stroke, 1992
- Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes.Stroke, 1992
- Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons.Stroke, 1991
- Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.Stroke, 1986
- Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period.Stroke, 1986
- An animal model of cerebral infarction. Homologous blood clot emboli in rats.Stroke, 1982